Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
HSS Journal , 2025
2022;13(5):e0181522
It covers the starting dose (2 mg), the first escalation (4 mg), and the second escalation (8 mg)
daily Tesamorelin, if selected) Weeks 2-12 Optimization Phase Bi-weekly nurse calls for dose tweaks and side-effect checks Nutrition & strength-training plan synced to peptide cycle Months 3-12 Progress & Maintenance Quarterly labs, DXA scans, and sleep-quality assessments Option to stack with GLP-1, lipotropics, or IV nutrient therapy 7
Step 3: Rinse Thoroughly rinse with lukewarm water until the skin feels clean and refreshed, then pat dry with a soft towel
Protocol 3: Comprehensive approach (advanced, with medical supervision) Goal: Full-spectrum immune modulation with organ support Phase 1 (Weeks 1-4): Foundation Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly BPC-157: 300 mcg subcutaneously, twice daily Phase 2 (Weeks 5-12): Add modulation Continue Phase 1 peptides Add KPV: 300-500 mcg subcutaneously, once daily Add Selank: 500 mcg intranasally, once daily Phase 3 (Weeks 13-16): Organ support cycle Continue Phase 2 peptides Add Thymalin: 10 mg course over 10 days Add targeted bioregulators based on affected organs (kidney, cardiac, vascular as needed) Phase 4 (Weeks 17-20): Rest and assess Discontinue all peptides Monitor disease activity markers Assess sustained benefits Plan next cycle based on results Monitoring: Full labs every 4 weeks, including CBC, CMP, complement levels, anti-dsDNA, CRP, ESR, urine protein/creatinine ratio
